Is bngo a good stock to invest in?
14 rows · 52 Week High: 4.451 52 Week Low: 0.70049 45-Day Moving Average: 2.239 90-Day Moving Average: ...
Is BioNano Genomics Inc (bngo) stock undervalued?
Apr 11, 2022 · Real-time trade and investing ideas on BioNano Genomics, Inc BNGO from the largest community of traders and investors. ... 52wk …
How often do you update the bngo stock projections?
Mar 30, 2022 · Bionano Genomics' stock was trading at $0.5770 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, BNGO shares have increased by 260.5% and is now trading at $2.08. View which stocks have been most impacted by COVID-19.
What is the bngo stock price prediction for 2026-06-15?
The current Bionano Genomics Inc [ BNGO] share price is $2.09. The Score for BNGO is 37, which is 26% below its historic median score of 50, and infers higher risk than normal. BNGO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
How much will BNGO be worth?
Bionano Genomics net worth as of April 13, 2022 is $0.62B. BioNano Genomics, Inc.
Is BNGO stock worth buying?
Bionano Genomics, Inc. may be overvalued. Its Value Score of F indicates it would be a bad pick for value investors. The financial health and growth prospects of BNGO, demonstrate its potential to underperform the market.
Does Ark hold BNGO?
At this time, ARK does not invest in BNGO. With that said, the company does appear to have some promise in its own right. Like all speculative small-cap companies, Bionano Genomics is a risky stock to own.
What kind of stock is BNGO?
Key DataLabelValueSectorCapital GoodsIndustryBiotechnology: Laboratory Analytical Instruments1 Year Target$10.00Today's High/Low$2.18/$2.0713 more rows
Is BNGO a pump and dump?
BNGO stock has suffered at the hands of a Ritalin-using pump and dump scheme making waves in 2021.May 7, 2021
Who owns Bionano genomics?
The Vanguard Group, Inc.
What ETF holds BNGO?
iShares Russell 2000 ETFETF.com Insight The largest ETF holder of BNGO is the iShares Russell 2000 ETF (IWM), with approximately 6.72M shares.
Is BNGO in ETF?
Bionano Genomics is a life sciences instrumentation company in the genome analysis space....ETFBNGOShares Out.289.61MMarket Cap.524.20MDiv/Shr0.00Div Yield0.0010 more rows
What does Bionano genomics do?
Bionano Genomics, Inc. provides a platform to analyze the long segments of genomic DNA and other biomolecules structural variations. The Company offers proprietary nanochannel chips, automated imaging instrument, integrated primary and secondary software, and application specific reagents.
What are analyst saying about BNGO stock?
Stock Price Forecast The 4 analysts offering 12-month price forecasts for Bionano Genomics Inc have a median target of 7.50, with a high estimate of 14.00 and a low estimate of 6.00. The median estimate represents a +262.32% increase from the last price of 2.07.
Is BNGO in Russell?
(Nasdaq: BNGO) announced today that it was added as a member of the US small-cap Russell 2000® Index, effective after the US market opens on Monday, June 28, 2021, as part of the 2021 Russell indexes reconstitution.Jun 28, 2021
How many shares does BNGO have?
83,218,166 sharesBioNano Genomics Inc (US:BNGO) has 292 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 83,218,166 shares.
Is Bionano Genomics a buy right now?
3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Bionano Genomics in the last year. There are currently 3...
How has Bionano Genomics' stock been impacted by Coronavirus (COVID-19)?
Bionano Genomics' stock was trading at $0.5770 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Healt...
When is Bionano Genomics' next earnings date?
Bionano Genomics is scheduled to release its next quarterly earnings announcement on Thursday, May 12th 2022. View our earnings forecast for Biona...
How were Bionano Genomics' earnings last quarter?
Bionano Genomics, Inc. (NASDAQ:BNGO) announced its quarterly earnings data on Tuesday, March, 1st. The company reported ($0.08) earnings per share...
What guidance has Bionano Genomics issued on next quarter's earnings?
Bionano Genomics updated its FY 2022 earnings guidance on Tuesday, March, 15th. The company provided earnings per share guidance of for the period....
What price target have analysts set for BNGO?
3 brokerages have issued 1-year target prices for Bionano Genomics' stock. Their forecasts range from $10.00 to $14.00. On average, they anticipate...
Who are Bionano Genomics' key executives?
Bionano Genomics' management team includes the following people: Robert Erik Holmlin , President, CEO, Secretary & Director Mark Oldakowski , Ch...
What is R. Erik Holmlin's approval rating as Bionano Genomics' CEO?
10 employees have rated Bionano Genomics CEO R. Erik Holmlin on Glassdoor.com . R. Erik Holmlin has an approval rating of 73% among Bionano Genomi...
Who are some of Bionano Genomics' key competitors?
Some companies that are related to Bionano Genomics include HORIBA (HRIBF) , Pacific Biosciences of California (PACB) , Olink Holding AB (publ)...
Is Bionano Genomics a buy right now?
What stocks does MarketBeat like better than Bionano Genomics?
4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Bionano Genomics in the last year. There are currently 1 hold rating and 3 buy ratings for the stock.
When is Bionano Genomics' next earnings date?
Wall Street analysts have given Bionano Genomics a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Bionano Genomics wasn't one of them.
How were Bionano Genomics' earnings last quarter?
Bionano Genomics is scheduled to release its next quarterly earnings announcement on Friday, November 12th 2021.#N#View our earnings forecast for Bionano Genomics.
How has Bionano Genomics' stock price been impacted by COVID-19 (Coronavirus)?
Bionano Genomics, Inc. (NASDAQ:BNGO) released its quarterly earnings results on Tuesday, August, 3rd. The company reported ($0.06) EPS for the quarter, missing the Zacks' consensus estimate of ($0.04) by $0.02. The firm had revenue of $3.86 million for the quarter, compared to analysts' expectations of $3.30 million.
What price target have analysts set for BNGO?
Bionano Genomics' stock was trading at $0.5770 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, BNGO shares have increased by 915.6% and is now trading at $5.86.#N#View which stocks have been most impacted by COVID-19.
What is R. Erik Holmlin's approval rating as Bionano Genomics' CEO?
4 analysts have issued 1 year price targets for Bionano Genomics' stock. Their forecasts range from $1.25 to $15.00. On average, they expect Bionano Genomics' stock price to reach $10.06 in the next twelve months.
Bionano Genomics Inc Stock Forecast
10 employees have rated Bionano Genomics CEO R. Erik Holmlin on Glassdoor.com. R. Erik Holmlin has an approval rating of 73% among Bionano Genomics' employees.
Will Bionano Genomics Inc Stock Go Up Next Year?
Over the next 52 weeks, Bionano Genomics Inc has on average historically risen by 416.8 % based on the past 2 years of stock performance.
Bionano Genomics Inc Stock Price History
Over the next 52 weeks, Bionano Genomics Inc has on average historically risen by 416.8% based on the past 2 years of stock performance.
Stock Predictions
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BNGO is experiencing selling pressure, which indicates risk of future bearish movement.
Signals & Forecast
Is Bionano Genomics Inc stock public?#N#Yes, Bionano Genomics Inc is a publicly traded company.
Support, Risk & Stop-loss
There are mixed signals in the stock today. The BioNano Genomics Inc. stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average.
Is BioNano Genomics Inc. stock A Buy?
BioNano Genomics Inc. finds support from accumulated volume at $5.55 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
What is BNGO in genomics?
BioNano Genomics Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
What is Benzinga's weighted scale?
BNGO is a leader in the digital cytogenetics niche. Its genome-imaging system, Saphyr, is arguably the most advanced hardware of its class today. Meanwhile, the global genomics market is expected to increase from $20 billion today to $80 billion by 2027.
What is a broker account?
For brokerage reviews, Benzinga created a weighted scale based on the following criteria: usability, services offered, customer service, education, research, mobile app, account minimums and fees. We aim to provide the most up-to-date, impactful and trustworthy reviews. For an in-depth look at our process, read the full methodology process.
What is market order?
Brokers serve as licensed intermediaries that process your orders on the financial markets. Opening an account is a safe, streamlined process and it enables you to invest through your computer or even your phone. Here is a list of top consideration when picking a broker:
The genetic testing specialist's tools could help to improve care for people with autism
Market order: A simple order that instructs your broker to purchase a selected number of shares on the market. This type of order does not specify a price, just a number of shares. Limit order: This type of order instructs your broker to purchase a selected number of shares only at a certain price (or better).
What happened
Joe honed his investing skills as an analyst for Stock Advisor, Supernova, and Fool One. He battle-tested his investment philosophy and strategies as portfolio manager of Tier 1, a market-crushing Motley Fool real-money portfolio that delivered 24.58% annualized returns during its existence.
So what
Shares of Bionano Genomics ( NASDAQ:BNGO) soared on Monday after the genome analysis company published a study on autism-risk genes. As of 1:50 p.m. EST today, Bionano's stock price was up 115%.
Now what
Bionano announced that its diagnostic services subsidiary, Lineagen, completed a comprehensive analysis of a single genome of a high-functioning individual with Autism Spectrum Disorder (ASD).
DD - Bionano Genomics Revenue Streams
Bionano's optical genome mapping platform, Saphyr, has been shown to be more effective at finding structural variants than its competitors. It's also significantly more cost-effective. For these reasons, analysts expect Saphyr to gain broader adoption in genome sequencing and research applications.
WHY DO WE CARE ABOUT SIMON AND ARK INVESTING? NO ONES CARES, BNGO WILL RUN ON ITS OWN!!!
I see a lot of us here trying to figure out exactly what BNGOs total addressable market is so I thought I would provide some of my DD. This is by no means complete, perfect research, just providing my opinions and theories as to how Bionano Genomics will make money, and where they can take this thing.
